Amarin | AMRN - EPS Earnings Per Share


Amarin reported $0.14 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amarin USD 0.14 0.06 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
DBV Technologies USD -0.24 1.31 Sep/2025
Esperion Therapeutics USD 0.26 0.42 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 1.54 0.5 Dec/2025